Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?

被引：0
|
作者：
George Grunberger
机构：
[1] Grunberger Diabetes Institute,Internal Medicine and Molecular Medicine and Genetics
[2] Wayne State University School of Medicine,Internal Medicine
[3] Oakland University William Beaumont School of Medicine,Internal Medicine, First Faculty of Medicine
[4] Charles University,undefined
来源：
Current Diabetes Reports | 2017年 / 17卷
关键词：
Type 2 diabetes mellitus; Treatment of type 2 diabetes; Antidiabetic medications; Drug side effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
    Chew, Emily Y.
    Ambrosius, Walter T.
    Davis, Matthew D.
    Danis, Ronald P.
    Gangaputra, Sapna
    Greven, Craig M.
    Hubbard, Larry
    Esser, Barbara A.
    Lovato, James F.
    Perdue, Letitia H.
    Goff, David C., Jr.
    Cushman, William C.
    Ginsberg, Henry N.
    Elam, Marshall B.
    Genuth, Saul
    Gerstein, Hertzel C.
    Schubart, Ulrich
    Fine, Lawrence J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 233 - 244
  • [32] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    C. J. Currie
    C. D. Poole
    E. A. M. Gale
    Diabetologia, 2009, 52 : 1766 - 1777
  • [33] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [34] Effects of Novel Antidiabetic Therapy on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus
    Siasos, Gerasimos
    Bletsa, Evanthia
    Stampouloglou, Panagiota K.
    Batzias, Konstantinos
    Antonopoulos, Alexios
    Paschou, Stavroula A.
    Tsigkou, Vasiliki
    Gouliopoulos, Nikolaos
    Mazaris, Savvas, Sr.
    Vogiatzi, Georgia
    Tsalamandris, Sotiris
    Oikonomou, Evangelos
    Zaromytidou, Marina
    Politou, Marianna
    Vryonidou, Andromachi
    Thanopoulou, Anastasia
    Tentolouris, Nikolas
    Tousoulis, Dimitris
    DIABETES, 2019, 68
  • [35] Antidiabetic Effects of Methysulfonlymethane (MSM), an Organosulfur Compound, in Obese Mice with Type 2 Diabetes
    Lima, Ines S.
    Seo, Ji A.
    Gaspar, Joana M.
    Lee, Seung-Hoon
    Kim, Young-Bum
    DIABETES, 2014, 63 : A294 - A294
  • [36] Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs
    Daniels, M. A.
    Kan, C.
    Willmes, D. M.
    Ismail, K.
    Pistrosch, F.
    Hopkins, D.
    Mingrone, G.
    Bornstein, S. R.
    Birkenfeld, A. L.
    PHARMACOGENOMICS JOURNAL, 2016, 16 (05): : 399 - 410
  • [37] Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs
    M A Daniels
    C Kan
    D M Willmes
    K Ismail
    F Pistrosch
    D Hopkins
    G Mingrone
    S R Bornstein
    A L Birkenfeld
    The Pharmacogenomics Journal, 2016, 16 : 399 - 410
  • [38] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Stuart W. Zarich
    Nature Reviews Endocrinology, 2009, 5 : 500 - 506
  • [39] Antidiabetic drugs and cognitive impairment in type 2 diabetes
    Matveeva, Mariia, V
    Samoilova, Yulia G.
    Zhukova, Natalia G.
    Oleynik, Oxana A.
    Rotkank, Mariya A.
    Leiman, Olga P.
    Kudlay, Dmitry A.
    MEDICAL SCIENCE, 2019, 23 (97) : 369 - 374
  • [40] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Zarich, Stuart W.
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (09) : 500 - 506
12345